Newsroom| Press Releases
View our collection of Press Releases
[SAN ANTONIO, TX – April 8, 2022] The 2022 Medical Device Excellence Awards program has selected Seno...
[SAN ANTONIO, TX – March 29, 2022] Seno Medical’s Imagio® Breast Imaging System has been named a finalist...
[SAN ANTONIO, TX – February 8, 2022] Seno Medical’s Imagio® Breast Imaging System has been named a finalist...
Prospective, controlled multi-center observational registry will include ~12 sites and 600 patients to...
Seno’s Imagio® Breast Imaging System helps physicians differentiate between benign and malignant breast...
New survey demonstrates women play a critical role in symptom(s) discovery
SAN ANTONIO, Nov. 14, 2019...
Seno Medical’s opto-acoustic technology could differentiate between breast cancer types
SAN ANTONIO,...
Seno Medical’s opto-acoustic technology could reduce false positives and identify cancer sub-types
SAN...
Partnership emphasizes breast health education and empowers women
SAN ANTONIO, May 12, 2019 – Seno Medical...
Imagio® is FDA approved for commercial distribution in the U.S. and ready for your patients. Contact our Sales Department today.
View featured stories in the Seno Medical industry.
View Seno Medical's Media Kit, which includes approved imagery, official logo and more.